Biogen (BIIB) Guides FY12; Sees Buying Back an Added $500M in Stock
Tweet
Share
E-mailGet Alerts BIIB Hot Sheet
Price: $217.76 +1.59%
Financial Fact:
Basic earnings per share attributable to Biogen Idec Inc.: 4.72
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Basic earnings per share attributable to Biogen Idec Inc.: 4.72
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Biogen (Nasdaq: BIIB) sees FY12 adj-EPS above $6.15, which compares to the Street estimate of $6.19.
Expecting to buyback an additional $500 million in common shares.
Expecting to buyback an additional $500 million in common shares.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen (BIIB) call put ratio 3.7 calls to 1 put with a focus on September calls
- Marti Technologies (MRT) Misses Q2 EPS by 9c ; Offers Guidance
- OSI Systems expands stock repurchase program by 1 million shares
Create E-mail Alert Related Categories
Guidance, Stock BuybacksSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
